Effects of L-arginine and L-citrulline Supplementation on Muscle Respiration
NCT ID: NCT03998800
Last Updated: 2022-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2019-05-01
2022-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of L-arginine Supplementation on Anaerobic Exercise Performance
NCT06475391
Effects of L-Arginine and Citrulline Malate Supplementation on Sport Performance in Physically Active Men
NCT06938126
Evaluation of Sports Supplements on Blood Flow
NCT04278053
L-arginine Supplementation and Resistance Exercise
NCT03827005
Supplementation Trial on Arginine With Metabolic Profiling
NCT03409380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
L-arginine and L-citrulline
10 days of supplementation with 1.5 g of L-arginine and 1.5 g of L-citrulline per day
Dietary Supplement
Dietary Supplement: L-arginine and L-citrulline supplement, L-arginine supplement, or placebo supplement (corn-starch) Subjects will complete 3 individual 10 day supplementation periods, separated by washout periods of approximately 2 weeks.
Endurance exercise on a cycle ergometer
On day 10 of each supplementation period, subjects will complete a performance test on a cycle ergometer to investigate their endurance performance.
L-arginine
10 days of supplementation with 3 g of L-arginine per day
Dietary Supplement
Dietary Supplement: L-arginine and L-citrulline supplement, L-arginine supplement, or placebo supplement (corn-starch) Subjects will complete 3 individual 10 day supplementation periods, separated by washout periods of approximately 2 weeks.
Endurance exercise on a cycle ergometer
On day 10 of each supplementation period, subjects will complete a performance test on a cycle ergometer to investigate their endurance performance.
Placebo (corn-starch)
10 days of supplementation with corn-starch
Dietary Supplement
Dietary Supplement: L-arginine and L-citrulline supplement, L-arginine supplement, or placebo supplement (corn-starch) Subjects will complete 3 individual 10 day supplementation periods, separated by washout periods of approximately 2 weeks.
Endurance exercise on a cycle ergometer
On day 10 of each supplementation period, subjects will complete a performance test on a cycle ergometer to investigate their endurance performance.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary Supplement
Dietary Supplement: L-arginine and L-citrulline supplement, L-arginine supplement, or placebo supplement (corn-starch) Subjects will complete 3 individual 10 day supplementation periods, separated by washout periods of approximately 2 weeks.
Endurance exercise on a cycle ergometer
On day 10 of each supplementation period, subjects will complete a performance test on a cycle ergometer to investigate their endurance performance.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* recreationally-active
* healthy BMI (≥18.5 and ≤24.9 kg/m2)
Exclusion Criteria
* history of gastric, digestive, cardiovascular, renal disease or any other orthopaedic diseases related to motor organs
* lidocaine allergy
* use of medication that may affect study measures
* contraindication to the biopsy procedures
* on medications that affect the immune system
* on Aspirin or other drugs known to prolong bleeding
* smoker
* user of dietary supplements currently or in the past one month
* a heavy drinker
18 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyowa Hakko Bio Co., Ltd.
INDUSTRY
Loughborough University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephen Bailey
Lecturer in Sport ad Exercise Nutrition
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen J Bailey, PhD
Role: PRINCIPAL_INVESTIGATOR
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Sport, Exercise and Health Sciences
Loughborough, Leicester, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R19-P010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.